Christopher Eisenschenk, PH.D
Shareholder
Phone: 352-375-8100Email: FCE@slepatents.com Email Me
Download vCard
Print PDF
Education
- B.S. Agriculture
University of Florida - Ph.D. Department of Microbiology and Cell Science
University of Florida - J.D. cum laude
University of Baltimore School of Law
Studied the pathogenicity of Gram-negative bacterial cells and the means by which bacterial cells evade the immune system of infected individuals
Areas of Practice
- U.S. and International Patent Procurement and Enforcement Strategy
- U.S. and International Patent Prosecution
- Patentability Opinions
- Freedom-to-Operate, Validity and Infringement Opinions
- Patent Appeals, Reexamination and Reissue
Technology Areas
- Cell Biology
- Immunology
- Infectious Disease
- Monoclonal Antibody Technology
- Biotechnology
- Chemical Technology
- Pharmaceuticals/ Medicinal Chemistry
- Agriculture/ Agricultural Biotechnology
- Medical Devices
Prior Professional Experience
- Supervisory Patent Examiner (SPE); USPTO: Biotechnology Groups
- Patent Examiner; USPTO: Biotechnology Groups
Awards and Recognitions
- Board Certified in Intellectual Property Law by The Florida Bar
- Bronze Medal for Superior Federal Service
Language Capabilities
- English
- German
PROFESSIONAL MEMBERSHIPS & ACTIVITIES
- Registered to Practice before the United States Patent and Trademark Office (USPTO)
- The Florida Bar
- Bar of the State of Maryland
- Guest Lecturer, University of Florida Levin College of Law
SELECTED PUBLICATIONS
- Mechanism of serum resistance among Brucella abortus isolates. (1999). Veterinary Microbiology, 68(3-4): 235-244.
- Serum sensitivity of field isolates and laboratory strains of Brucella abortus. (1995). American Journal of Veterinary Research, 56(12): 1592-1598.
- Purification of the ninth component of the bovine complement cascade. (1992). American Journal of Veterinary Research, 53(4): 435-439.
SELECTED PATENTS
- 11,099,193: Methods for Diagnosing or Monitoring Muscular Dystrophies
- 11,072,784: Esterases and Uses Thereof
- 11,072,803: Hybrid Dual Recombinant AAV Vector Systems for Gene Therapy
- 11,066,470: Humanized Antibodies with Increased Stability
- 11,014,962: Method for Protein Purification
- 10,968,281: Anti-LSP1 Antibody
- 10,947,176: Antimalarial Compositions and Uses Thereof
- 10,900,060: Method of Producing Terpenes or Terpenoids
- 10,894,035: Use of Indole Compounds to Stimulate the Immune System
- 10,889,640: Tau-Binding Antibodies
- 10,888,440: Intraosseous Stent